Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “2022”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5
All sourcesNASA NTRSDOE OSTI
NASA NTRSDate not supplied

Crystal Growth in the SUBSA furnace in MSG: 2002 to 2022

In 2002, the investigation “Solidification Using a Baffle In Sealed Ampoules (SUBSA)” was the first investigation to utilize the Microgravity Science Glovebox (MSG) Facility on the International Space Station (ISS). The SUBSA furnace was designed for growth of indium antimonide. It features a transparent section, which allows a side view of the melt, the solid-liquid (SL) interface and the growing crystal. In 2002, four Te-doped and three Zn-doped InSb crystals were grown in microgravity. Subsequently, the SUBSA furnace was used in several materials science investigations, including growing the radiation detector materials, InI and Cs2LiYCl6:Ce from the melt and vapor phase (2017 to 2019) and “Brazing of Aluminum alloys in Space (BRAINS)”. A review of the SUBSA furnace features and parameters will be presented, including the design of the growth ampoules, charge preparation, and the procedures used to grow InSb (in 2002) and InI (in 2019).

Aleksandar Ostrogorsky↗
NASA NTRSDate not supplied

One-Carbon Metabolism and SANS 2022 Update

Spaceflight Associated Neuro-ocular Syndrome, or SANS, affects a subset of astronauts (1, 2), and biochemical evidence has documented differences in those astronauts (3). Specifically, they had higher circulating concentrations of metabolites of the one-carbon metabolic pathway (1C), including homocysteine, and these concentrations were higher before flight (3). After ruling out many potential confounding factors in these otherwise healthy individuals (e.g., sex, kidney function, vitamin status, coffee consumption), a study of genetics was warranted. In an initial pilot effort, we documented a genetic predisposition to develop ophthalmic changes after long-duration space flight (4). That is, from a limited study of 5 single-nucleotide polymorphisms (SNPs), we found that the G allele for the MTRR A66G SNP was associated with a greater risk of choroidal folds and cotton-wool spots after flight, and the C allele for SHMT1 C1420T was protective against optic disc edema (4). These data provide a potential pathway for understanding why some individuals develop SANS, while others do not. The initial pilot study of 5 SNPs yielded striking findings, but the 1C pathway is far more complex. An effort was undertaken to examine more than 500 1C SNPs to see if a broader examination could help illuminate this association. That work is ongoing. The astronaut findings led us to advocate for the inclusion of 1C pathway genetic and biochemistry testing on other SANS-related projects, noting that genetics might help identify responders, non-responders, or outliers. The first such effort yielded evidence of an association of specific forms of the MTRR and SHMT-1 SNPs and vitamin B12 status with end-tidal CO2 after acute carbon dioxide exposure (5). The second such effort led to the identification that individuals exposed to strict head-down tilt and CO2 for 30-d who developed optic disc edema also had risk alleles for the two SNPs described above (6). Additionally, we identified a clinical population with many characteristics either attributed or purported to be involved in the ocular changes seen in affected astronauts: women with polycystic ovary syndrome (PCOS). PCOS is a condition of androgen excess and anovulatory menstrual cycles. The shared characteristics and clinical findings between SANS and PCOS generally include higher circulating homocysteine concentrations, increased retinal nerve fiber layer thickness, increased androgen concentrations (or responses), and altered carbohydrate metabolism. To our knowledge, no study has examined whether women with PCOS have asymptomatic ophthalmic anomalies observed in astronauts with SANS. While researchers have evaluated the one-carbon metabolism pathway polymorphisms of PCOS patients, and initial studies show an association with certain one-carbon polymorphisms, none have looked at the set of SNPs identified in our studies that are associated with ophthalmic changes in astronauts. Accordingly, we designed a study to evaluate the association of one-carbon pathway SNPs and ophthalmic findings in patients with PCOS and/or IIH compared to controls. Subjects provided blood samples for vitamin and one carbon biochemistry analyses, an extensive analysis of >500 SNPs associated with one carbon metabolism and had eye examinations and ocular imaging. Data analysis are underway. The data collected to date have shown associations between one carbon pathway biochemistry and genetics and incidence of SANS. The mechanisms for SANS has yet to be identified, although many hypotheses exist. Based on our data, we have developed (8, 9) and expanded (6) a multi-hit hypothesis for how these seemingly disparate findings could be linked. While intriguing, the hypothesis represents the starting point for further research. We aim to clarify the relationship between B-vitamin status and genetics with regard to the risk of SANS. Ultimately, understanding the mechanism(s) behind this will provide a means to predict, prevent, or treat these ophthalmologic pathologies in astronauts, and terrestrial populations.

S M Smith↗
NASA NTRSDate not supplied

NASA Advanced Space Suit Pressure Garment System Status and Development Priorities 2022

This paper discusses the current focus of NASA’s Advanced Space Suit Pressure Garment Technology Development team’s efforts, the status of that work, and a summary of longer-term technology development priorities and activities. For the past two years, the team has focused on the development and detailed design of the Extra-vehicular Mobility Unit (xEMU) to support two parallel missions: A 2023 deadline for delivery of the xEMU International Space Station (ISS)Demonstration configuration, and a planetary walking suit configuration to support landing on the Moon in 2024. The baselined design of the xEMU will be reviewed. The results of Design Verification Testing (DVT) will be presented and its ability to provide confidence in the hardware’s ability to meet flight requirements will be discussed. To the extent possible, an impact assessment of the Exploration Extravehicular Activity Services (xEVAS) Contract will be provided. Finally, a brief review of longer-term pressure garment challenges and technology gaps will be presented to provide an understanding of the advanced pressure garment team’s technology investment priorities and needs for future exploration missions.

xEMU↗
NASA NTRSDate not supplied

NASA Environmental Control and Life Support Technology Development for Exploration: 2021 to 2022 Overview

Over the past year, significant progress has occurred in technology development, ground testing, and ISS technology demonstrations within the NASA Environmental Control and Life Support (ECLSS) community. This paper provides a technology development update in the following capability areas: life support, environmental monitoring, fire safety, and logistics. Technologies for exploration missions must be reliable in their operation which support crewed mission phases. However, they also need to be put into a reduced use or dormant states to support uncrewed mission phases and then successfully and reliably returned to a nominal state to support crew. Multi-year demonstration of systems operation across this range of conditions are essential to mission success. Project overviews will include how the current activity supports the goal of multi-year demonstrations, planned follow-on activities, and what type of exploration mission elements are targeted for infusion. Technologies must be demonstrated and validated early enough to inform early exploration element milestone reviews (mission concept reviews, systems requirement reviews and no later than preliminary design reviews) so that supporting vehicle systems can also be matured. Consequently, for low technology readiness activities, it is important to also identify which mission elements they might infuse into and how they may offer potential operational, dormancy, or mass benefits. While low TRL technology timelines may not support initial mission needs, early infusion is still reasonable with sufficient testing to validate performance and reliability.

Life Support↗
NASA NTRSDate not supplied

NASA Crew Health & Performance Capability Development for Exploration: 2021 to 2022 Overview

Radiation, reduced gravity, distance from earth, isolation and confinement, and habitation within artificially created and controlled life support environments are hazards that present risk to human space explorers. In many cases, research is required to characterize those risks and help identify risk mitigation strategies. Where new capabilities are necessary to maintain crew health and performance (CHP) during exploration missions, a multi-step process is followed: 1) a Capability Gap is defined; 2) a plan or “roadmap” to develop that capability is established based on agency priorities and anticipated mission development timelines; and 3) work defined on the roadmap is then initiated as resources allow, with the objective that the capability will be available in time to support the future mission. Over the past year, significant progress has occurred in CHP technology development, ground testbed development, ground-based testing, and in preparations for ISS technology demonstrations. This paper provides a development update in the following capability areas: crew health countermeasures, EVA physiology and performance, food and nutrition, exploration medical capabilities, and radiation. Project overviews will include descriptions of CHP development activities over the past year, the human system risks and capability gaps being targeted, as well as planned follow-on activities and anticipated program infusion points.

Andrew F J Abercromby↗